213 related articles for article (PubMed ID: 29843131)
21. Mibefradil reduces hepatic glucose output in HepG2 cells via Ca
Ying D; Mengya S; Peilin L; Lingong Z; Huan M; Jing X; Le Z; Kebin Z; Bin C; Jun Y; Shaodong G; Zihui X
Eur J Pharmacol; 2021 Sep; 907():174296. PubMed ID: 34224697
[TBL] [Abstract][Full Text] [Related]
22. Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway.
Alaaeldin R; Abdel-Rahman IAM; Hassan HA; Youssef N; Allam AE; Abdelwahab SF; Zhao QL; Fathy M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946711
[TBL] [Abstract][Full Text] [Related]
23. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE
Liang M; Wang L; Wang W
Cell Signal; 2023 Aug; 108():110707. PubMed ID: 37164143
[TBL] [Abstract][Full Text] [Related]
24. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
[TBL] [Abstract][Full Text] [Related]
25. Retinol binding protein 4 mediates MEHP-induced glucometabolic abnormalities in HepG2 cells.
Wang F; Chang C; Li R; Zhang Z; Jiang H; Zeng N; Li D; Chen L; Xiao Y; Chen W; Wang Q
Toxicology; 2019 Aug; 424():152236. PubMed ID: 31228551
[TBL] [Abstract][Full Text] [Related]
26. Sonchus oleraceus Linn extract enhanced glucose homeostasis through the AMPK/Akt/ GSK-3β signaling pathway in diabetic liver and HepG2 cell culture.
Chen L; Lin X; Fan X; Qian Y; Lv Q; Teng H
Food Chem Toxicol; 2020 Feb; 136():111072. PubMed ID: 31877369
[TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
[TBL] [Abstract][Full Text] [Related]
28. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
29. The impact of sitagliptin in palmitic acid-induced insulin resistance in human HepG2 cells through the suppressor of cytokine signaling 3/phosphoinositide 3-kinase/protein kinase B pathway.
Ma R; Quan L; Aleteng QQ; Li L; Zhu J; Jiang S
J Physiol Pharmacol; 2023 Apr; 74(2):. PubMed ID: 37453092
[TBL] [Abstract][Full Text] [Related]
30. Wheat germ peptide improves glucose metabolism and insulin resistance in HepG2 hepatocytes via regulating SOCS3/IRS1/Akt pathway.
Song H; Huang Q; Zhang Y; Shen X
Nutr Res; 2023 Dec; 120():135-144. PubMed ID: 38000279
[TBL] [Abstract][Full Text] [Related]
31. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
32. Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxia.
Shin MK; Yao Q; Jun JC; Bevans-Fonti S; Yoo DY; Han W; Mesarwi O; Richardson R; Fu YY; Pasricha PJ; Schwartz AR; Shirahata M; Polotsky VY
J Appl Physiol (1985); 2014 Oct; 117(7):765-76. PubMed ID: 25103977
[TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity.
Mo J; Zhou Y; Yang R; Zhang P; He B; Yang J; Li S; Shen Z; Chen P
Pharmacol Rep; 2019 Dec; 71(6):1160-1167. PubMed ID: 31675670
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of marein on high glucose-induced glucose metabolic disorder in HepG2 cells.
Jiang B; Le L; Zhai W; Wan W; Hu K; Yong P; He C; Xu L; Xiao P
Phytomedicine; 2016 Aug; 23(9):891-900. PubMed ID: 27387397
[TBL] [Abstract][Full Text] [Related]
35. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
Meng Z; Lv J; Luo Y; Lin Y; Zhu Y; Nie J; Yang T; Sun Y; Han X
Endocrinology; 2009 Dec; 150(12):5284-93. PubMed ID: 19837872
[TBL] [Abstract][Full Text] [Related]
36. Oral Porphyromonas gingivalis translocates to the liver and regulates hepatic glycogen synthesis through the Akt/GSK-3β signaling pathway.
Ishikawa M; Yoshida K; Okamura H; Ochiai K; Takamura H; Fujiwara N; Ozaki K
Biochim Biophys Acta; 2013 Dec; 1832(12):2035-43. PubMed ID: 23899607
[TBL] [Abstract][Full Text] [Related]
37. Gegen Qinlian Decoction Ameliorates Hepatic Insulin Resistance by Silent Information Regulator1 (SIRT1)-Dependent Deacetylation of Forkhead Box O1 (FOXO1).
Sui M; Chen G; Mao X; Wei X; Chen Y; Liu C; Fan Y
Med Sci Monit; 2019 Nov; 25():8544-8553. PubMed ID: 31719515
[TBL] [Abstract][Full Text] [Related]
38. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
39. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling.
Song JJ; Wang Q; Du M; Li TG; Chen B; Mao XY
Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27506476
[TBL] [Abstract][Full Text] [Related]
40. FOXO1 is downregulated in obese mice subjected to short-term strength training.
Pereira RM; da Cruz Rodrigues KC; Sant'Ana MR; da Rocha AL; Morelli AP; Veras ASC; Gaspar RS; da Costa Fernandes CJ; Teixeira GR; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Cell Physiol; 2022 Nov; 237(11):4262-4274. PubMed ID: 36125908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
